• Home
  • >
  • Windlas Biotech Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/windlas-biotech-ltd.png Logo

Windlas Biotech Ltd Financial Statement

Windlas Biotech Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue175.73165.38155.91
Operating Expense149.35141.88133.99
Net Profit16.9515.114.03
Net Profit Margin9.659.139
Earning Per Share8.157.266.75
EBIDTA25.2923.2722.02
Effective Tax Rate17.1319.0219.93

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Windlas Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual513.08465.93427.6
Operating Expenses Annual452.86413.51372.91
Operating Profit Annual70.1959.1336
Interest Annual0.791.421.29
Depreciation12.1711.9312.47
Net Profit Annual42.6338.0915.83
Tax Annual14.417.486.17

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Windlas Biotech Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning0.5715.9323.9
Cash Flow from Operations60.979.1311.46
Cash Flow from Investing-14.11-154.58-20.2
Cash Flow from Financing-43.74130.090.78
Cash Flow at the End3.690.5715.93

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Windlas Biotech Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)13.6812.6913.47
PBIT Margin (%)11.2710.0810.44
PBT Margin (%)-32.982.35
Net PROFIT Margin (%)8.318.281.17
Return On Networth / Equity (%)10.712.8315.19
Return On Networth /Employed(%)14.2314.7718.88
Return On Assets (%)10.4712.082.12
Total Debt / Equity(X)0.010.070.14
Asset Turnover Ratio (%)1.261.461.81

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Windlas Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual110.3891.6295.94
Total Current Assets Annual353.54381.65194.31
Non Current Assets Annual175.44109.36101.81
Total Shareholders Funds Annual402.27394.78199.12
Total Assets Annual528.98491.01296.12

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Windlas Biotech Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Windlas Biotech Ltd has a market capitalization of 1,065.61 Cr. Value Research classifies it as a Small-Cap company.

Yes, Windlas Biotech Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023, Windlas Biotech Ltd recorded a total revenue of approximately 630.96 Cr marking a significant milestone in the company's financial performance.

Windlas Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.2% annually, respectively..

Windlas Biotech Ltd's current PE ratio is 18.31.

Windlas Biotech Ltd's ROCE averaged 14.4% from the FY ending March 2022 to 2024, with a median of 14.2%. It peaked at 17.2% in March 2024, reflecting strong capital efficiency over the period..

Windlas Biotech Ltd's latest EBIT is Rs. 78.2 Cr, surpassing the average EBIT of Rs. 61.01 Cr over the 5 years..